
Recent Articles
Government Money Should Set Moderna Stock Back on the Path to Growth
By
Todd Shriber, InvestorPlace Contributor
Yes, Moderna is advanced, relative to many rivals, in its efforts to bring a Covid-19 vaccine to market. However, the combination of the gravity of this situation – industries, jobs and most importantly, human lives, hang in the balance – and the timeline of getting a treatment to market make for a situation where upside in MRNA stock is unlikely to be linear.
3 Monthly Dividend Stocks in Danger
By
Todd Shriber, InvestorPlace Contributor
Monthly dividend stocks appeal to income investors, but plenty of members of this group are at risk of negative dividend action.
7 OTC Stocks Perfect for Ordinary Investors
By
Todd Shriber, InvestorPlace Contributor
Some OTC stocks are big, familiar names with credible business models and powerful brands. Investors shouldn't pass on this exciting space.
Stay Clear of Exxon Mobil Stock as It Struggles to Protect the Dividend
By
Todd Shriber, InvestorPlace Contributor
Speaking of oil prices, the recovery hasn't been sharp enough to prevent Exxon from issuing some gloomy commentary. In a recent regulatory filing, the oil major said that if prices don't rally some more – it didn't say by how much – before the end of 2020, it could be forced to write-off 20% of output, or the equivalent of 4.5 billion barrels of crude.
Etsy Has the Makings of Long-Term E-Commerce Winner
By
Todd Shriber, InvestorPlace Contributor
ETSY stock is one of the brightest stars in online retail this year, but investors shouldn't focus on masks. There's more to like here.
Caesars Entertainment Is Born Again
By
Todd Shriber, InvestorPlace Contributor
Investors looking for a potential big winner among casino equities should give CZR stock a look because it has multiple tailwinds.
7 Travel Stocks to Buy Banking On Pent-Up Demand
By
Todd Shriber, InvestorPlace Contributor
Travel stocks are down, but not out, and some of these names could be ready to rally over the near-term as pent-up demand is realized.
Wells Fargo Will Have Investors Waiting for a Return to Glory
By
Todd Shriber, InvestorPlace Contributor
Wells Fargo stock is one of the more downtrodden banks and that's saying something. The near-term outlook is murky at best.
MGM Stock Will Survive the Pandemic, but It Isn’t Going to Thrive
By
Todd Shriber, InvestorPlace Contributor
On July 30, the Bellagio operator delivered second-quarter results that were more dismal than expected and that's saying something because with commercial casinos across the U.S shuttered large parts, or in some cases, all of the June quarter, the earnings bar is low for the gaming industry. MGM said it lost $1.67 a share on revenue of $289.81 million in the April through June period. Analysts expected a loss of $1.60 on turnover of $408.95 million.
7 Biotech ETFs to Buy Now For Covid-19 And Beyond
By
Todd Shriber, InvestorPlace Contributor
Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.